This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Vertex (VRTX) Stock Up 70% in a Year's Time: Here's Why
by Zacks Equity Research
Vertex Pharmaceuticals' (VRTX) stock rallies on consistent expansion in patient population through label expansions of Kalydeco and Orkambi and positive data readout from pivotal studies.
Biogen (BIIB) Q4 Earnings Miss, Sales Top, 2018 View Upbeat
by Zacks Equity Research
Biogen (BIIB) beats estimates for earnings but misses the same for sales in Q4. The outlook issued for 2018 looks fairly upbeat.
Varian Medical (VAR) Beats Q1 Earnings & Revenue Estimates
by Zacks Equity Research
HyperArc and Halcyon platforms drive Varian Medical's (VAR) Q1 results.
Amarin (AMRN) Soars: Stock Adds 9.9% in Session
by Zacks Equity Research
Amarin Corporation (AMRN) was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Sanofi to Acquire Haemophilia Focused Bioverativ, Stock Dips
by Zacks Equity Research
Sanofi (SNY) is set to acquire blood disorder focused biopharmaceutical company, Bioverativ, for $11.6 billion.
PerkinElmer Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
PerkinElmer's (PKI) shares hit a new 52-week high on the back of broad product spectrum and acquisition-led growth.
Key Factors to Influence PerkinElmer's (PKI) Q4 Earnings
by Zacks Equity Research
PerkinElmer (PKI) solid product portfolio, positive market trends and acquisition are likely to drive earnings in the fourth quarter.
4 Great Healthcare Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
An ageing population and steady demand for healthcare services continue to make stocks from the sector a lucrative option.
New Strong Buy Stocks for January 12th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Strong Buy Stocks for July 25th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
New Strong Sell Stocks for June 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Kennametal, Bioverativ and Apple highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Kennametal, Bioverativ and Apple highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Bioverativ (BIVV)
by Kevin Cook
Biogen spin-off just reported its first quarter and made an acquisition, but estimates were trimmed
Top Ranked Momentum Stocks to Buy for May 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 10th:
New Strong Buy Stocks for May 5th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday